Enaltus, LLC has sold its brand ScarAway® to Perrigo Company plc

Enaltus, LLC, a portfolio company of HealthEdge Investment Partners, LLC, has sold ScarAway®, a leading US over-the-counter (OTC) scar management brand, to Perrigo Company plc. Financial details have not been disclosed.

ScarAway® is a market leader in the scar management category in the OTC consumer channel. It is the fastest-growing brand in the category and is currently the number one 100% silicone scar treatment brand and the number two brand in the overall consumer scar category in the US. ScarAway® provides a complete range of scar management solutions, including gels, serum and long and short fabric-backed silicone sheets. The brand has distribution across all retailers in the drug, mass, food, specialty and e-commerce channels, with a presence in more than 35,000 doors in the US.

Founded in 1887 and headquartered in Dublin, Ireland, Perrigo Company plc (NYSE:PRGO), together with its subsidiaries, develops, manufactures, markets, and distributes OTC consumer goods and pharmaceutical products worldwide. It offers its products in various categories, including cough, cold, allergy and sinus, analgesic, gastrointestinal, smoking cessation, infant formula and food, animal health, diagnostic products, natural health and vitamins, personal care and derma-therapeutics, lifestyle, and anti-parasite; consumer healthcare products; and vitamins, minerals, and supplements. The company sells its products through retail drug, supermarket, mass merchandise chains, wholesalers, pharmacies, drug and grocery stores, parapharmacies and hospitals as well as through a network of pharmacy sales force and pharmacists in North America, Europe, Australia, Israel, China, and Latin America.

Founded in 1995 and based in Suwanee, Georgia, Enaltus develops, manufactures and markets skincare products for professional and consumer markets primarily for mothers and babies in the US and internationally. The company’s products include Kelo-cote, a topical silicone gel and spray for the treatment and prevention of abnormal scars, including hypertrophic scars and keloids; bioCorneum, a silicone treatment for minimizing the appearance of scars; Belli, a skincare cosmetic for expecting and nursing mothers, and babies; and CapriClear Moisturizing Spray, a solution that provides relief from dry, flaky, and irritated skin. Enaltus also offers Arnika Forte, a natural supplement for recovering from bruising, swelling, and pain associated with soft tissue injuries. The company serves physicians, plastic surgeons, dermatologists, OB/GYN’s and others. It offers its products directly to physicians and consumers as well as through national and independent retailers.

Oaklins' team in Los Angeles acted as advisor to Enaltus, LLC in this transaction.